Patents by Inventor Michael F. Gross

Michael F. Gross has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11938004
    Abstract: The present disclosure relates to absorbent articles having a waist gasketing element, with the gasketing element having an adhesive zone and one or more adhesive-free zones. At least a portion of the waist gasketing element is adhesively attached to a chassis of the absorbent article. Additionally, a portion of the waist gasketing element is mechanically attached to a portion of the absorbent article.
    Type: Grant
    Filed: May 1, 2020
    Date of Patent: March 26, 2024
    Assignee: The Procter & Gamble Company
    Inventors: Jeromy Thomas Raycheck, Thorsten Rinnert, Urmish Popatlal Dalal, Darren Lee Goad, Michael Brian Quade, Jason Edward Naylor, Uwe Schneider, Thomas F. Gross
  • Patent number: 11932833
    Abstract: Peroxide treatment compositions for use in laundry capable of providing sanitization through the wash e.g., for use with a detergent, where a peroxide activator is stabilized without the presence of phosphorus-containing compounds (e.g., phosphorus-containing stabilizers), through use of a nonionic surfactant (e.g., alkoxylated alcohol) with a cloud point above 45° C. Use of a single nonionic surfactant, or a surfactant package that may include a small fraction (e.g., less than 0.5%) of sodium lauryl sulfate or another anionic surfactant has been found to be surprisingly effective at stabilizing the peroxide/activator combination, even where water content may be 85% or greater. The composition can have a pH of 5 or less (e.g., 3 to 4). The composition may be free of other anionic surfactants, cationic surfactants, zwitterionic surfactants, amphoteric surfactants, magnesium salts, borates and boric acid, hydroxides, chelating agents, various amine oxides, ethoxylated amines, and the like.
    Type: Grant
    Filed: February 16, 2022
    Date of Patent: March 19, 2024
    Assignee: THE CLOROX COMPANY
    Inventors: Nancy A. Falk, Timothy P. Mui, Evan Rumberger, Xuanrong Guo, Fanny Frausto, Michael Capracotta, Dennys D. Pena Calderon, David R. Scheuing, Claire E. J. Dentinger, Stephen F. Gross, Nicholas S. Norberg, Shakera Thamanna
  • Patent number: 7743516
    Abstract: A trim installation tool, attachable to the jamb of a window or door, which aids in the installation of trim. The tool provides for the marking of a consistent reveal around a door or window when installing trim. The tool also provides a surface which may be used to provide support to the end of a tape measure when performing measurements. Additionally, the tool may provide support for the trim being installed around the door or window.
    Type: Grant
    Filed: June 23, 2008
    Date of Patent: June 29, 2010
    Inventor: Michael F. Gross
  • Publication number: 20090313838
    Abstract: A trim installation tool, attachable to the jamb of a window or door, which aids in the installation of trim. The tool provides for the marking of a consistent reveal around a door or window when installing trim. The tool also provides a surface which may be used to provide support to the end of a tape measure when performing measurements. Additionally, the tool may provide support for the trim being installed around the door or window.
    Type: Application
    Filed: June 23, 2008
    Publication date: December 24, 2009
    Inventor: Michael F. Gross
  • Publication number: 20090312307
    Abstract: Novel heterocyclo compounds useful as inhibitors of potassium channel function (especially inhibitors of the Kv1 subfamily of voltage gated K+ channels, especially inhibitors Kv1.5 which has been linked to the ultra-rapidly activating delayed rectifier K+ current IKur), methods of using such compounds in the prevention and treatment of arrhythmia and IKur-associated conditions, and pharmaceutical compositions containing such compounds.
    Type: Application
    Filed: August 11, 2009
    Publication date: December 17, 2009
    Inventors: John Lloyd, Yoon T. Jeon, Heather Finlay, Lin Yan, Michael F. Gross, Serge Beaudoin
  • Patent number: 7582654
    Abstract: Novel heterocyclo compounds useful as inhibitors of potassium channel function (especially inhibitors of the Kv1 subfamily of voltage gated K+ channels, especially inhibitors Kv1.5 which has been linked to the ultra-rapidly activating delayed rectifier K+ current IKur), methods of using such compounds in the prevention and treatment of arrhythmia and IKur-associated conditions, and pharmaceutical compositions containing such compounds.
    Type: Grant
    Filed: July 21, 2005
    Date of Patent: September 1, 2009
    Assignees: Bristol-Myers Squibb Company, Icagen, Inc.
    Inventors: John Lloyd, Yoon T. Jeon, Heather Finlay, Lin Yan, Michael F. Gross, Serge Beaudoin
  • Patent number: 7435824
    Abstract: Compounds useful as prodrugs of potassium channel inhibitor compounds, in particular as prodrugs of Kv1.5 channel inhibitors.
    Type: Grant
    Filed: January 3, 2005
    Date of Patent: October 14, 2008
    Assignees: Bristol-Myers Squibb Company, Icagen Inc.
    Inventors: Michael F. Gross, John Lloyd
  • Patent number: 7244744
    Abstract: Compounds, compositions and methods are provided which are useful in the treatment of diseases through the inhibition of sodium ion flux through voltage-dependent sodium channels. More particularly, the invention provides substituted piperidines, and compositions containing these compounds. Also provided are methods using the compounds of the invention for the treatment of central or peripheral nervous system disorders, particularly pain and chronic pain by blocking sodium channels associated with the onset or recurrance of the indicated conditions. The compounds, compositions and methods of the present invention are of particular use for treating neuropathic or inflammatory pain by the inhibition of ion flux through a channel that includes a PN3 subunit.
    Type: Grant
    Filed: November 1, 2002
    Date of Patent: July 17, 2007
    Assignee: Icagen, Inc.
    Inventors: Michael F. Gross, Robert N. Atkinson, Matthew S. Johnson
  • Patent number: 7223782
    Abstract: Compounds, compositions and methods are provided which are useful in the treatment of diseases through the inhibition of sodium ion flux through voltage-dependent sodium channels. More particularly, the invention provides pyrazole-amides and -sulfonamides, compositions and methods that are useful in the treatment of central or peripheral nervous system disorders, particularly pain and chronic pain by blocking sodium channels associated with the onset or recurrance of the indicated conditions. The compounds, compositions and methods of the present invention are of particular use for treating neuropathic or inflammatory pain by the inhibition of ion flux through a channel that includes a PN3 subunit.
    Type: Grant
    Filed: November 1, 2002
    Date of Patent: May 29, 2007
    Assignee: Icagen, Inc.
    Inventors: Robert N. Atkinson, Michael F. Gross
  • Patent number: 7202253
    Abstract: Novel cycloalkyl compounds useful as inhibitors of potassium channel function (especially inhibitors of the Kv1 subfamily of voltage gated K+ channels, especially inhibitors Kv1.5 which has been linked to the ultra-rapidly activating delayed rectifier K+ current IKur), methods of using such compounds in the prevention and treatment of arrhythmia and IKur-associated conditions, and pharmaceutical compositions containing such compounds.
    Type: Grant
    Filed: November 24, 2004
    Date of Patent: April 10, 2007
    Assignees: Bristol-Myers Squibb Company, Icagen, Inc.
    Inventors: John Lloyd, Yoon T. Jeon, Heather Finlay, Lin Yan, Michael F. Gross, Serge Beaudoin
  • Patent number: 7098335
    Abstract: Compounds, compositions and methods are provided which are useful in the treatment of diseases through the inhibition of sodium ion flux through voltage-dependent sodium channels. More particularly, the invention provides pyrazolopyrimidines, compositions and methods that are useful in the treatment of central or peripheral nervous system disorders, particularly pain and chronic pain by blocking sodium channels associated with the onset or recurrance of the indicated conditions. The compounds, compositions and methods of the present invention are of particular use for treating neuropathic or inflammatory pain by the inhibition of ion flux through a channel that includes a PN3 subunit.
    Type: Grant
    Filed: November 12, 2004
    Date of Patent: August 29, 2006
    Assignee: Icagen, Inc.
    Inventors: Robert N. Atkinson, Michael F. Gross, Albert M. van Rhee
  • Patent number: 7005436
    Abstract: Novel heterocyclo compounds useful as inhibitors of potassium channel function (especially inhibitors of the Kv1 subfamily of voltage gated K+ channels, especially inhibitors Kv1.5 which has been linked to the ultra-rapidly activating delayed rectifier K+ current IKur), methods of using such compounds in the prevention and treatment of arrhythmia and IKur-associated conditions, and pharmaceutical compositions containing such compounds.
    Type: Grant
    Filed: April 16, 2003
    Date of Patent: February 28, 2006
    Assignees: Bristol Myers Squibb Company, Icagen, Inc.
    Inventors: John Lloyd, Yoon T. Jeon, Heather Finlay, Lin Yan, Michael F. Gross, Serge Beaudoin
  • Patent number: 6989398
    Abstract: Benzanilides are provided which are voltage-dependent potassium channel openers. Methods of using the benzanilides of the invention are also provided.
    Type: Grant
    Filed: February 2, 2004
    Date of Patent: January 24, 2006
    Assignee: ICAgen, Inc.
    Inventors: Grant A. McNaughton-Smith, Michael F. Gross, Alan D. Wickenden
  • Patent number: 6881753
    Abstract: Indanes, benzopyrans and analogues thereof are potassium channel inhibitors and blockers of IKur and have the structure: where A, B, D, Q, X1, R, R1, X2 and R2 are as defined herein. These compounds are useful as antiarrhythmic agents. In addition, a method is provided for preventing cardiac arrhythmia employing the above compounds.
    Type: Grant
    Filed: April 14, 2004
    Date of Patent: April 19, 2005
    Assignee: Bristol-Myers Squibb Co.
    Inventors: John Lloyd, Heather J. Finlay, Wayne Vaccaro, Karnail S. Atwal, Michael F. Gross, Kerry L. Spear
  • Patent number: 6849634
    Abstract: Compounds useful as potassium channel inhibitors and especially useful for the treatment of cardiac arrhythmias and cell proliferative disorders are described.
    Type: Grant
    Filed: December 7, 2001
    Date of Patent: February 1, 2005
    Assignee: ICAgen
    Inventors: Serge Beaudoin, Aimee D. Reed, Michael F. Gross
  • Patent number: 6833371
    Abstract: Compounds, compositions and methods are provided which are useful in the treatment of diseases through the inhibition of sodium ion flux through voltage-dependent sodium channels. More particularly, the invention provides pyrazolopyrimidines, compositions and methods that are useful in the treatment of central or peripheral nervous system disorders, particularly pain and chronic pain by blocking sodium channels associated with the onset or recurrance of the indicated conditions. The compounds, compositions and methods of the present invention are of particular use for treating neuropathic or inflammatory pain by the inhibition of ion flux through a channel that includes a PN3 subunit.
    Type: Grant
    Filed: November 1, 2002
    Date of Patent: December 21, 2004
    Assignee: Icagen, Inc.
    Inventors: Robert N. Atkinson, Michael F. Gross, Albert M. van Rhee
  • Publication number: 20040220170
    Abstract: Compounds of the present invention modulate PN3 in mammals and are useful in treating pain in mammals.
    Type: Application
    Filed: May 1, 2003
    Publication date: November 4, 2004
    Inventors: Robert N. Atkinson, Irene Drizin, Robert J. Gregg, Michael F. Gross, Michael E. Kort, Lei Shi
  • Publication number: 20040192710
    Abstract: Indanes, benzopyrans and analogues thereof are potassium channel inhibitors and blockers of IKur and have the structure 1
    Type: Application
    Filed: April 14, 2004
    Publication date: September 30, 2004
    Inventors: John Lloyd, Heather J. Finlay, Wayne Vaccaro, Karnail S. Atwal, Michael F. Gross, Kerry L. Spear
  • Patent number: 6784189
    Abstract: Indanes, benzopyrans and analogues thereof are potassium channel inhibitors and blockers of IKur and have the structure where A, B, D, Q, X1, R, R1, X2 and R2 are as defined herein. These compounds are useful as antiarrhythmic agents. In addition, a method is provided for preventing cardiac arrhythmia employing the above compounds.
    Type: Grant
    Filed: November 15, 2002
    Date of Patent: August 31, 2004
    Assignee: Bristol-Myers Squibb Company
    Inventors: John Lloyd, Heather J. Finlay, Wayne Vaccaro, Karnail S. Atwal, Michael F. Gross, Kerry L. Spear
  • Publication number: 20040157829
    Abstract: Benzanilides are provided which are voltage-dependent potassium channel openers. Methods of using the benzanilides of the invention are also provided.
    Type: Application
    Filed: February 2, 2004
    Publication date: August 12, 2004
    Applicant: ICAgen, Inc.
    Inventors: Grant A. McNaughton-Smith, Michael F. Gross, Alan D. Wickenden